Topic

Florida

A collection of 504 issues

Do You Qualify for Retevmo (Selpercatinib) Coverage by UnitedHealthcare in Florida? Decision Tree & Next Steps

Quick Answer: Getting Retevmo (Selpercatinib) Covered by UnitedHealthcare in Florida You likely qualify for Retevmo coverage if you have RET fusion-positive cancer confirmed by FDA-approved testing and haven't responded to or can't tolerate standard treatments. UnitedHealthcare requires prior authorization through OptumRx. Submit via the UnitedHealthcare provider
6 min read

How to Get Lutathera Covered by Blue Cross Blue Shield in Florida: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Lutathera Covered in Florida Blue Cross Blue Shield of Florida requires prior authorization for Lutathera (lutetium Lu-177 dotatate), typically through their medical benefit. Success depends on documenting SSTR-positive imaging, failed somatostatin analog therapy, and proper NET diagnosis. Start today: Call the member services number on your insurance
7 min read

How to Get Somatuline Depot (Lanreotide) Covered by Blue Cross Blue Shield in Florida: 2025 Prior Authorization Guide

Answer Box: Getting Somatuline Depot Covered by Florida Blue Florida Blue Cross Blue Shield requires prior authorization for Somatuline Depot (lanreotide) with 1-year approval for FDA-approved indications (acromegaly, GEP-NETs, carcinoid syndrome). Coverage criteria include documented inadequate response to octreotide, specialist oversight, and quantity limits of one syringe per 28 days.
6 min read

Resources to Get Signifor LAR Covered by UnitedHealthcare in Florida: Forms, Portals & Appeals Guide

Answer Box: Getting Signifor LAR Covered by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Signifor LAR (pasireotide) through OptumRx for Cushing's disease or acromegaly treatment in Florida. Submit via the UnitedHealthcare Provider Portal with endocrinologist prescription, surgical history showing incomplete resection or ineligibility, and biochemical evidence (≥2
5 min read